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Mechanistic Target of Rapamycin
Complex 1 Promotes the
Expression of Genes Encoding
Electron Transport Chain Proteins
and Stimulates Oxidative
Phosphorylation in Primary Human
Trophoblast Cells by Regulating
Mitochondrial Biogenesis
Fredrick J. Rosario1, Madhulika B. Gupta2, Leslie Myatt3, Theresa L. Powell1,4,
Jeremy P. Glenn5, Laura Cox5,6 & Thomas Jansson1
Trophoblast oxidative phosphorylation provides energy for active transport and protein synthesis,
which are critical placental functions influencing fetal growth and long-term health. The molecular
mechanisms regulating trophoblast mitochondrial oxidative phosphorylation are largely unknown. We
hypothesized that mechanistic Target of Rapamycin Complex 1 (mTORC1) is a positive regulator of key
genes encoding Electron Transport Chain (ETC) proteins and stimulates oxidative phosphorylation in
trophoblast and that ETC protein expression is down-regulated in placentas of infants with intrauterine
growth restriction (IUGR). We silenced raptor (mTORC1 inhibition), rictor (mTORC2 inhibition) or
DEPTOR (mTORC1/2 activation) in cultured term primary human trophoblast (PHT) cells. mTORC1
inhibition caused a coordinated down-regulation of 18 genes encoding ETC proteins representing
all ETC complexes. Inhibition of mTORC1, but not mTORC2, decreased protein expression of ETC
complexes I–IV, mitochondrial basal, ATP coupled and maximal respiration, reserve capacity and
proton leak, whereas activation of mTORC1 had the opposite effects. Moreover, placental protein
expression of ETC complexes was decreased and positively correlated to mTOR signaling activity in
IUGR. By controlling trophoblast ATP production, mTORC1 links nutrient and O2 availability and growth
factor signaling to placental function and fetal growth. Reduced placental mTOR activity may impair
mitochondrial respiration and contribute to placental insufficiency in IUGR pregnancies.
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The placenta constitutes the primary maternal-fetal interface and its immunologic, transport, metabolic and
endocrine functions are critical for normal fetal growth and development. The syncytiotrophoblast, the transporting and hormone-producing epithelium of the human placenta, requires a large amount of energy in the form
of ATP to support processes such as active transport and protein synthesis. These ATP needs are met, in part, by
mitochondrial respiration, however the molecular mechanisms regulating oxidative phosphorylation in primary
human trophoblast (PHT) cells are largely unknown.
As in other cells, syncytiotrophoblast mitochondria are critical for a multitude of biological processes including energy metabolism, redox signaling, steroid synthesis, and apoptosis1. Impaired placental mitochondrial
function2 and ATP production, placental insufficiency3,4, and hypoxia3 may act in concert to reduce fetal growth.
Perturbations in trophoblast mitochondrial function could lead to excessive generation of reactive oxygen and
nitrogen species5, contributing to altered placental function in IUGR, gestational diabetes, and maternal obesity6–8. Moreover, placental mitochondrial dysfunction has been implicated in the programming of atherosclerosis in cases of placental insufficiency5.
Mechanistic Target of Rapamycin (mTOR) is a serine/threonine kinase that is activated by amino acids, glucose, oxygen and growth factor signaling and promotes cell growth and metabolism. mTOR exists in two complexes, mTOR Complex 1 (mTORC1) and 2, with the protein Regulatory-associated protein of mTOR (Raptor)
associated to mTORC1 and Rapamycin-insensitive companion of mammalian target of rapamycin (Rictor)
associated to mTORC2. When activated, mTORC1 phosphorylates p70 ribosomal protein S6 kinase 1 (S6K1)
and 4E-binding protein 1 (4E-BP1) promoting protein translation, lipid biogenesis and metabolism as well as
suppressing autophagy9–14. mTORC2 phosphorylates protein kinase B (AKT), Protein kinase C alpha (PKCα)
and Serum and Glucocorticoid-regulated Kinase 1 (SGK1) and regulates cytoskeletal organization and metabolism15,16. DEPTOR, a protein containing two DEP (Dishevelled, Egl-10, Pleckstrin) domains, is an endogenous
inhibitor of both mTORC1 and 2 signaling17. Placental mTOR activity is decreased in human intrauterine growth
restriction (IUGR)18–20 as well as in rodent21 and non-human primate models of IUGR22. On the other end of
the fetal growth spectrum, placental mTOR activity is activated in obese women giving birth to larger babies23
as well as in a mouse model of maternal obesity associated with fetal overgrowth24. We recently demonstrated
that placental mTOR functions as a positive regulator of amino acid transporter system A and L25 and folate
transporters26.
mTORC1 activation increases mitochondrial DNA copy number and promotes the expression of genes critical for mitochondrial metabolism27,28 including genes encoding for proteins involved in oxidative phosphorylation29,30. Recent studies in MCF7 cells suggest that mTORC1 controls mitochondrial activity and biogenesis
through 4E-BP1 dependent translation31. Furthermore, rapamycin-treated leukemic cells display reduced mitochondrial function, resulting in energy production via enhanced aerobic glycolysis in preference over mitochondrial respiration31. However, the mechanisms involved and the specific role of mTORC1 and mTORC2 signaling
in the regulation of mitochondrial respiration in the placenta remain to be established.
Using gene silencing approaches in cultured primary human trophoblast cells and studies of placental tissue
from normal and IUGR pregnancies we tested the hypothesis that mTORC1 is a positive regulator of key genes
encoding Electron Transport Chain (ETC) proteins and stimulates oxidative phosphorylation in trophoblast and
that ETC protein expression is down-regulated in placentas of infants with intrauterine growth restriction.

Materials and Methods

Ethical Approval and Study Participants. PHT cells were isolated from placentas of uncomplicated term

pregnancies collected with informed consent at the Labor and Delivery Unit at University Hospital San Antonio
with approval of the Institutional Review Board of the University of Texas Health Science Center San Antonio.
Placentas from pregnancies complicated by intrauterine growth restriction (IUGR) and women delivering appropriate-for-gestational age (AGA) infants were collected at St. Joseph’s Health Care Centre, London, Ontario,
Canada. These women were enrolled after informed consent was obtained, according to a protocol approved by
the University of Western Ontario Health Sciences Research Ethics Board. The recruitment procedure, including
inclusion and exclusion criteria, has been described in detail previously20. All experimental protocols and methods were approved by a University of Texas Health Science Center San Antonio committee and St. Joseph’s Health
Care Centre, London, Ontario, Canada. The informed consent was obtained from all subjects.

Materials

Oligomycin, FCCP [4-(trifluoromethoxy) phenylhydrazone], and antimycin A were obtained from Sigma and
dissolved in DMSO as 2.5 mM stock solutions. A human oxidative phosphorylation (OXPHOS) antibody cocktail
and antibodies targeting NDUFB8, TOM20, Cytochrome b and c antibodies were purchased from Abcam. Raptor
and rictor antibodies were obtained from Cell Signaling Technology.

Isolation and Culture of Primary human Trophoblasts (PHT). Placentas were collected immediately
following delivery by cesarean section at term without labor. PHT cells were isolated and cultured in vitro using a
well-established protocols26,32. Cells were plated in either 60 mm culture dishes (~7.5 × 106 cells/dish for RNA isolation or Western blot analysis) or in Seahorse XF-24 plates for mitochondrial respiration experiments (~8 × 105
cells/well for RNAi mediated gene silencing) and cultured in 5% CO2, 95% atmosphere air at 37 °C for 90 h. Cell
culture media (DMEM/Hams F-12, supplemented with L-glutamine, penicillin, streptomycin, gentamycin, and
10% fetal bovine serum) was changed daily. The study design, including the time point of siRNA mediated silencing/activation of mTORC1/C2 signaling and measurements of various parameters, is illustrated in Supplemental
Fig. 1.
Mononuclear cytotrophoblast cells isolated from term placentas typically start to aggregate into monolayers of
mononucleated cells within about 12 h of plating. By 72 h in culture, most cytotrophoblast cells have differentiated
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into multinuclear syncytiotrophoblast as evidenced by the expression of cytokeratin-7, a trophoblast specific
marker, and secretion of human chorionic gonadotropin-β (β-hCG), produced exclusively by syncytiotrophoblast33,34. Furthermore, we recently reported that in our cultured PHT cells expression of syncytin, a marker of
syncytialization cells increased over the culture period confirming syncytialization of our cell population35. Cell
viability and degree of syncytialization are maintained to beyond 90 hours in culture25,36 allowing investigators
to study syncytiotrophoblast function between 72 and 90 h. Studies at 90 h in culture ensure that maximum gene
silencing has been achieved following siRNA transfection at 18 hours in culture, as in the current report.

RNA interference-mediated silencing. Dharmafect 2 transfection reagent (Thermo Scientific, Rockford,
IL) and small interfering RNAs (siRNAs) (Sigma-Aldrich, St. Louis, MO), targeting raptor (100 nM; sense,
5′CAGUUCACCGCCAUCUACA), rictor (100 nM; sense, 5′CGAUCAUGGGCAGGUAUUA), or DEPTOR
(SASI_1297010-H/5582, 1297011-H) were used. Control cells were transfected with a non-coding scrambled
sequence (100 nM; sense: 5′GAUCAUACGUGCGAUCAGATT). siRNA were added to cultured primary trophoblast cells (~8 × 105 cells/well in 24 well plate; ~7.5 × 106 cells in 60 mm dish) after 18 h in culture, incubated for
24 h, and removed, and fresh medium was added to wells37. At 90 hours in culture, efficiency of target silencing
was determined at the protein level (expression of raptor, rictor or DEPTOR) using Western blot.
RNA isolation from PHT cells. RNA was isolated from cultured PHT cells at 90 hr in culture using TRIzol
Reagent (Invitrogen, Carlsbad, CA) according to the manufacturer’s instructions. RNA was resuspended in 100 µl
DEPC-treated water. RNA quality was determined using an Agilent 2100 Bioanalyzer (Agilent Technologies, Inc.,
Santa Clara, CA) and RNA concentrations confirmed by quantitation using a NanoDrop 8000 spectrophotometer (Thermo Fisher Scientific, Wilmington, DE).

™

Gene expression profiling in PHT cells. Whole genome expression profiling was performed using gene
arrays (HumanHT-12 v4 Expression BeadChips, Illumina Inc., San Diego, CA). cRNA was synthesized and biotin labeled (cat. no. 1750, Ambion, Austin, TX) according to manufacturer’s instructions. Total RNA was used
for first and second strand cDNA synthesis followed by in vitro transcription to synthesize biotin-labeled cRNA.
Following quality check, cRNA was hybridized to Human HT-12 v4 Expression BeadChips (Illumina Inc.).
Individual cRNA samples were used to interrogate each BeadChip (Scramble siRNA for raptor, n = 4; Raptor
siRNA, n = 4; Scramble siRNA for rictor, n = 4; Rictor siRNA, n = 4). Gene expression was detected and cleaned
using GenomeStudio software (Illumina Inc.) and filtered using quality score (>0.95). Gene array data were
all-median normalized and log2 transformed (GeneSifter), and differentially expressed genes were identified by
t-test (p < 0.05). Genes significantly different in expression were overlaid onto Kyoto Encyclopedia of Genes and
Genomes (KEGG) pathways38–40 using GeneSifter. Z-scores were calculated in GeneSifter. Statistical enrichment
of differentially expressed genes in pathways was determined by calculating z-scores using the following formula:
z-score = (r − n(R/N))/SQRT(n(R/N) (1 − (R/N))(1 − (n − 1/N − 1)); where R = total number of genes meeting
selection criteria, N = total number of genes measured, r = number of genes meeting selection criteria with the
specified GO term, and n = total number of genes measured with the specific GO term. Pathway enrichment
analysis of differentially expressed genes has been shown to reveal pathways that are impacted in that biological
system41. KEGG is a comprehensive knowledge base for assisting in the biological interpretation of large-scale
molecular datasets. Using KEGG pathway enrichment analysis provides a means to statistically filter gene expression data within the framework of annotated biological systems38. Calculations were performed using GeneSifter
software default settings without user input. Pathways were considered significantly different between groups if
the z-score for that pathway was greater than +2.0 or less than −2.042. Biological pathways were mapped by using
online tool KEGG (http://www.genome.jp/kegg/; Kyoto encyclopedia for genes and genomes)38–40,43.
Western blotting.

Cells were rinsed once with ice-cold PBS and lysed in ice-cold buffer (PBS containing
0.05% SDS and protease, phosphatase inhibitor). Subsequently, cells were scraped, collected, and sonicated.
The soluble fraction of cell lysates were isolated by centrifugation at 13,000 g for 10 min at 4 °C. Total protein
concentration in the cell lysate was determined using Bradford’s reagent (Bio-Rad). Cell lysate proteins (10 μg)
were separated on 4–20% precast linear gradient gels (Invitrogen). Membranes were incubated overnight
at 4 °C with primary antibody diluted in 1% nonfat milk (wt/vol) in TBST and detected using an appropriate
peroxidase-conjugated secondary antibody. Products were visualized by ECL chemiluminescence (Millipore).
Band intensities were measured using the G-box system (Syngene). Anti-β actin was from Sigma-Aldrich, St.
Louis, Mo. Target band densities were normalized to loading using beta-actin. For each protein target the mean
density of the control sample bands was assigned an arbitrary value of 1. All individual densitometry values were
expressed relative to this mean.

Assessment of Mitochondrial Function. Mitochondrial function in PHT cells was measured using a
Seahorse XF24 analyzer (Seahorse Biosciences) as described44. The experimental details explaining the measurement of Oxygen Consumption Rate (OCR) in PHT cells is provided as Supplemental Material. Basal respiration
was calculated from four baseline OCR readings. ATP coupled, maximum respiration, reserve capacity, proton
leak, and non-mitochondrial respiration were calculated from OCR readings following the injection of oligomycin (1 μM), FCCP (1 μM), and antimycin A (1.5 μM).
PHT cell ATP Levels.

ATP levels were determined in cell lysates at 90 hr of culture using the Enliten ATP
assay (Promega) according to the manufacturer’s protocol.

Mitochondrial Biogenesis.

Mitochondrial DNA copy number. At 90 hr of culture total genomic DNA
was isolated from cultured PHT cells using the GenElute Mammalian Genomic DNA Miniprep Kit
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Control (n = 19)

IUGR (n = 25)

Maternal age (years)

25.9 ± 1.29

28.7 ± 1.23

BMI (kg/m2)*

28.3 ± 2.6

26.8 ± 2.0

Gestational age (weeks)

33.9 ± 0.95

35.7 ± 0.61

Birth weight (g)

2493 ± 236

1804 ± 110†

55.9 ± 4.6

2.4 ± 0.3§

Birth weight percentile

‡

Placental weight (g)

566 ± 42.0

394 ± 18.4||

Fetal sex (M/F)

7/12

8/17

Mode of delivery (C/V)

6/13

15/10

Table 1. Selected clinical data. Data are presented as means ± S.E.M. Abbreviations: C, caesarean section;
F, female; M, male; n, numbers; V, vaginal delivery. *n = 10 (control) and 18 (IUGR); ‡by corresponding
gestational age; †P < 0.05; ||P < 0.01; §P < 0.0001.

(Sigma-Aldrich). Mitochondrial DNA copy number was determined using the Nuvaquant human mito/nuclear
DNA ratio kit (Calbiochem) involving real-time PCR and using primers for mitochondrial 16S rRNA and nuclear
β2-microglobulin according to the manufacturer’s protocol.
Citrate synthase activity. Was measured in PHT cell lysates at 90 hr of culture using a commercial kit from
Detroit R&D according to the manufacturer’s protocol. Cultured PHT cells were homogenized using lysis reagent
(C3228; Sigma).
Staining of mitochondria in PHT cells. Isolated PHT cells (500,000 cells/well) were grown on chamber slides
(Lab-Tek) for 90 hours. At 90 hr, cells were incubated with mito green indicator (Abcam) in a 37 °C, 5% CO2
for 10 minutes. Subsequently, cells were fixed in paraformaldehyde (4%) for 20 min. Confocal microscopy was
performed using Zeiss LSM 780 microscope at 63x magnification using oil immersion. Images were captured in
the same laser settings with four Z-step of 0.4 um. For densitometric analysis of mitochondrial staining, Image J
Software (version 1.52a) was used. In each section, at least five randomly selected microscopic fields were used to
calculate mitochondria staining density per mm2 and data were averaged to represent a single placenta.

Placental mTORC1 signaling and expression of mitochondrial electron transport complexes in
IUGR. Placentas from pregnancies complicated by intrauterine growth restriction (IUGR) and women deliv-

ering appropriate-for-gestational age (AGA) infants were collected within 15 minutes of delivery as described
elsewhere20. Selected clinical data for the control and IUGR groups are listed in Table 1. There was no significant
difference in maternal age, body mass index (BMI) or gestational age between the control and the IUGR groups.
Birth weight was 28% lower (P < 0.01) and placental weight was reduced by 36% (P < 0.001) in the IUGR group
compared with controls. The decidua basalis and chorionic plate were removed and villous tissue was dissected
and rinsed in cold physiological saline. The villous tissue was transferred to cold buffer D (250 mM sucrose,
10 mM HEPES, pH 7.4) containing 1:100 dilution of protease and phosphatase inhibitors (Sigma-Aldrich, St.
Louis, MO) and homogenized on ice with a Polytron (Kinematica, Luzern, Switzerland). Placental homogenates were frozen in liquid nitrogen and stored at −80 °C until further processing. The phosphorylation of key
proteins in the mTORC1 [as reported in20], raptor, rictor, DEPTOR and mitochondrial electron transport complexes expression in placental homogenates of IUGR and control group were determined using Western blots as
described above for cells.

Data presentation and statistics. The number of experiments (n) represents the number of placentas
studied. Each condition was studied in triplicate, and data were averaged to represent trophoblast cells isolated from one placenta. Data are presented as means ± S.E.M or + S.E.M. Array data from each sample were
all-median normalized and log2 transformed. Statistical analyses of array data were performed by t-test using
GeneSifter software (Geospiza, Inc.) for pairwise comparisons (GeneSifter.Net, VizX Labs, Seattle, WA; GEO
accession number: GSE40878). Statistical significance of differences between control and experimental groups
in studies of protein expression and mitochondrial function was assessed using Student’s t-test. A P-value < 0.05
was considered significant.

Results

Validation of silencing efficiency. To confirm that the siRNA reduced expression of the proteins
encoded by the targeted genes, we performed western blots on siRNA-transfected PHT cells at 90 h of culture
(Supplemental Fig. 2). Raptor or rictor siRNA silencing in PHT cells (Supplemental Fig. 2; n = 4/each group)
markedly decreased the protein expression of raptor and rictor, respectively.
Inhibition of mTORC1 caused a decrease in expression of genes involved in oxidative phosphorylation. In a separate unpublished study we used whole genome expression profiling in raptor (mTORC1

inhibition) and rictor (mTORC2 inhibition) silenced PHT cells as an approach to identify novel trophoblast
functions regulated by mTOR signaling. Leveraging this discovery data set we specifically asked the question
if trophoblast mTORC1 regulates the transcription of genes encoding ETC proteins, in analogy with other cell
types27,45,46. Indeed, expression of 18 genes encoding ETC proteins representing all five complexes involved in
mitochondrial respiration was all down-regulated in response to raptor silencing (Supplemental Fig. 3), but not
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Figure 1. Expression of mitochondrial electron transport chain (ETC) proteins in PHT cells with mTORC1 or
mTORC2 inhibition. Protein expression of ETC complex I (NDUFB8), complex II (SDHB), III (UQCRC2), IV
(COXII) and V (V-ATP5A in PHT cells transfected with either scramble (n = 4) or raptor (mTORC1 inhibition,
n = 4) or rictor (mTORC2 inhibition, n = 4) siRNA. Full length Western blot is shown. The data are from a
representative experiment, and similar results were obtained from three other experiments.
following rictor silencing (data not shown). In agreement with these findings, mitochondrial oxidative phosphorylation was one of the top ranked down-regulated pathways following mTORC1 inhibition using the Kyoto
Encyclopedia of Genes and Genomes (KEGG; Supplemental Fig. 3).

Effect of mTORC1 or mTORC2 inhibition on protein expression of electron transport chain
complexes. Energy derived from the oxidation of carbohydrates, fats and proteins are transformed to ATP

by the mitochondrial respiratory chain which is composed of five separate protein complexes (I–V) present in
the inner mitochondrial membrane47. To confirm that the observed down-regulation of genes involved in mitochondrial respiration was associated with corresponding changes in protein expression, we performed Western
blotting on mitochondrial complexes using an antibody cocktail (Total OXPHOS Human WB Antibody Cocktail
(ab110411), abcam, UK), recognizing epitopes of purified subunits of II (SDHB), III (UQCRC2), IV (MTCOX1),
and V (ATP5α). Total OXPHOS Human WB Antibody Cocktail did not detect Complex I (NDUFB8) in PHT cell
lysates so we used Anti-NDUFB8 antibody (ab155903) for this purpose. Inhibition of mTORC1 decreased the
expression levels of subunits of complexes I, II, III, IV and V as compared to control (n = 4/each group; Fig. 1).
In contrast, protein expression of mitochondrial complexes was unaffected by mTORC2 inhibition (n = 4/each
group; Fig. 1).

Effect of mTORC1 inhibition on TOM20 (translocase of the outer membrane 20) protein expression in PHT cells. Biogenesis of functional and competent mitochondria requires the import and assembly

of proteins synthesized in the cytoplasm. Mitochondria contain more than 1000 proteins that are imported from
the cytoplasm through the translocase of the outer mitochondrial membrane (TOM complex). Proteins to be
translocated into the mitochondria are targeted by the presequence receptors Tom20 or Tom70 and enter the
mitochondria via the pore, which is mainly formed by Tom4048. Cytochrome b (Cyt b) is an integral part of
Complex III, and in its absence the entire complex will fail to assemble resulting in a complete inhibition of oxidative phosphorylation. Cytochrome c is associated with the inner membrane of the mitochondria and interacts
with redox partners of complex III and complex IV, which is a part of the mitochondrial electron transfer chain.
We determined the expression levels of TOM20, cytochrome b and c, which are central for the regulation of
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Figure 2. Effect of mTORC1 inhibition on mitochondrial respiration in PHT cells. Mitochondrial respiration
was measured in PHT cells at 90 hours of culture following inhibition of mTORC1 by silencing of raptor.
Individual oxygen consumption rate (OCR) parameters (basal, ATP-coupled and maximal respiration, nonmitochondrial respiration, reserve capacity and proton leak) were calculated based on total cellular protein and
expressed relative to control PHT cells (transfected with scramble siRNA). Data are presented as mean + S.E.M.
*P < 0.05 vs scramble siRNA cells, paired student’s T-test, n = 4 independent experiments.

mitochondrial function, following mTOR inhibition in PHT cells. As shown in Supplemental Fig. 4, inhibition of
mTORC1 signaling decreased the expression of TOM20, cytochrome b and c as compared to control (n = 6/each
group; Supplemental Fig. 4).

Inhibition of mTORC1 decreases mitochondrial respiration in cultured PHT cells.

We assessed
mitochondrial function in PHT cells by determining OCR following sequential addition of pharmacological
inhibitors to probe the function of individual components of the respiratory chain. The design of these experiment is provided in Supplemental Methods. To estimate the proportion of the basal OCR coupled to ATP synthesis, ATP synthase (Complex V) was inhibited by oligomycin, which decreases the OCR rate to the extent to
which the cells are using mitochondria to generate ATP. The remaining OCR is ascribed to proton leak across
the mitochondrial membrane. To determine the maximal OCR that the cells can sustain, the proton ionophore
FCCP was injected. Lastly, antimycin A was injected to inhibit electron flux through Complex III which causes a
dramatic suppression of the OCR. The remaining OCR is attributable to O2 consumption due to the formation of
mitochondrial ROS and non-mitochondrial sources. The reserve respiratory capacity was calculated as the maximal rate minus the basal rate and presents a parameter which is available to cells for increased work to cope with
stress. As shown in Fig. 2 (n = 4/each group), inhibition of mTORC1 decreased the basal respiration (p = 0.02),
ATP-coupled respiration (p = 0.04), maximum respiration (p = 0.01), reserve capacity (p = 0.04) and proton leak
(p = 0.04) as compared to control. Non-mitochondrial respiration was not significantly affected (p = 0.08) by
mTORC1 inhibition (Fig. 2).

No effect of mTORC2 inhibition on mitochondrial respiration in cultured PHT cells. We also
studied the effects of mTORC2 inhibition on mitochondrial function in cultured PHT cells. Basal, ATP-coupled
and maximum respiration, as well as reserve capacity, non-mitochondrial respiration, and proton leak were unaffected by mTORC2 inhibition by rictor silencing (n = 4/each group; Fig. 3).
Activation of mTORC1 and 2 increases mitochondrial respiration in cultured PHT cells. Activation

of mTORC1 and mTORC2 using DEPTOR silencing significantly increased basal respiration (p = 0.03),
ATP-coupled respiration (p = 0.03), maximum respiration (p = 0.009), and reserve capacity (p = 0.005) as compared to control. Non-mitochondrial respiration (p = 0.2) and proton leak (p = 0.2) were unaffected by activating
mTORC1 and mTORC2 (n = 4/each group; Fig. 4).
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Figure 3. Effect of mTORC2 inhibition on mitochondrial function in PHT cells. Mitochondrial respiration was
measured in PHT cells at 90 hours of culture following inhibition of mTORC2 by silencing of rictor. Individual
oxygen consumption rate (OCR) parameters (basal, ATP-coupled and maximal respiration, non-mitochondrial
respiration, reserve capacity and proton leak) were calculated based on total cellular protein and expressed
relative to control PHT cells (transfected with scramble siRNA). Data are presented as mean + S.E.M., paired
student’s T-test, n = 4 independent experiments.

Effect of mTOR on cellular ATP levels. The effect of mTOR inhibition on PHT cell ATP levels was examined. The cellular ATP content was decreased by 50% in raptor silenced cells as compared to control (P < 0.01,
n = 6/each group; Fig. 5a). However, the cellular ATP levels were comparable between control and rictor silenced
PHT cells (Fig. 5b). In contrast, ATP levels were significantly (P < 0.05, n = 6/each group) increased in mTOR
activated PHT cells (DEPTOR silenced) as compared to control (Fig. 5c).
Mitochondrial DNA copy number.

To explore the mechanism that may account for the decline in PHT
cellular ATP levels following mTORC1 inhibition, we utilized a RT-PCR approach to measure changes in mitochondrial biogenesis (Fig. 5d–f). The mitochondrial DNA copy number was significantly decreased in raptor
silenced cells as compared to control (P < 0001, n = 6/each group; Fig. 5d), whereas mTORC2 inhibition (rictor
silencing) did not affect the mitochondrial biogenesis in PHT cells (Fig. 5e). In DEPTOR silenced cells, mitochondrial DNA copy number was significantly increased as compared to control (P < 0.05, n = 6/each group;
Fig. 5f).

Mitochondrial citrate synthase activity. We also estimated the mitochondrial content by measuring cit-

rate synthase activity. mTORC1 inhibition showed a significant reduction in citrate synthase activity (P < 0.0001,
n = 6/each group; Fig. 5g), whereas citrate synthase activity was comparable between rictor silenced and control
PHT cells (Fig. 5h). DEPTOR silencing significantly increased the citrate synthase activity as compared to control
(P < 0.01, n = 6/each group; Fig. 5i).

Visualization of mitochondria in PHT cells using immunofluorescence. To provide additional support for the idea that mTORC1 signaling influences mitochondrial biogenesis, we used confocal microscopy to
visualize mitochondria in cultured PHT cells. We observed that in response to raptor silencing mitochondria
content decreased as compared to control PHT cells (Fig. 6).
Placental mTORC1 signaling is associated with the protein expression of mitochondrial ETC
complexes in human pregnancy. To explore the clinical relevance of our findings, we examined the rela-

tionship between placental mTORC1 signaling and the protein expression of mitochondrial electron transport
chain complexes in placentas collected from control and IUGR pregnancies. The protein expression of ETC complex I (Fig. 7a) and II-V (Supplementary Figs 5a–8a) were significantly reduced in IUGR placentas. Placental
raptor and rictor expressions were significantly decreased in the IUGR as compared to control (Supplementary
Fig. 9). In contrast, placental DEPTOR expression was increased in the IUGR group as compared to control
(Supplementary Fig. 9). Placental mTORC1 functional readouts signaling in the same placentas has been reported
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Figure 4. Effect of activation of mTORC1 and 2 on mitochondrial respiration in PHT cells. Mitochondrial
respiration was measured in PHT cells at 90 hours of culture following activation of mTORC1/2 by silencing
of DEPTOR. Individual oxygen consumption rate (OCR) parameters (basal, ATP-coupled and maximal
respiration, non-mitochondrial respiration, reserve capacity and proton leak) were calculated based on total
cellular protein and expressed as relative to PHT cells (transfected with scramble siRNA). Data are presented as
mean + S.E.M. *P < 0.05 vs scramble siRNA cells, paired student’s T-test, n = 4 independent experiments.

elsewhere20. With few exceptions, placental mTORC1 signaling functional readouts of phosphorylated 4E-BP1
(Thr-37/46) and S6 kinase (Thr-389) were positively correlated with mitochondrial ETC complexes (Fig. 7 and
Supplementary Figs 5–8). The 4E-BP1 protein prevents translation initiation by binding eukaryotic translation
initiation factor 4E (eIF4E) and phosphorylation of 4E-BP1 interferes with this binding, thereby activating protein translation. As a consequence, both the increased total expression of 4E-BP1 and the decreased phosphorylation of 4E-BP1 at Thr37/46 will promote binding of eIF4E resulting in inhibition of cap-dependent translation
initiation in the IUGR placenta. Placental 4E-BP1 expression negatively correlated with mitochondrial ECT complexes I and V (Fig. 7 and Supplementary Figs 5–8).

Discussion

We report that mTORC1, but not mTORC2, is a positive regulator of mitochondrial oxidative phosphorylation in
primary human trophoblast cells mediated by influencing mitochondrial biogenesis. These findings extend previous reports of mTORC1 regulation of mitochondrial respiration in cell lines to human primary non-proliferative
cells. In addition, we provide evidence that placental protein expression of ETC complexes was decreased and
positively correlated to mTOR signaling activity in IUGR. By controlling trophoblast ATP production, which is
essential for energizing active transport and protein synthesis, mTORC1 links nutrient and O2 availability and
growth factor signaling to placental function and fetal growth. Reduced placental mTOR activity may impair
mitochondrial respiration and contribute to placental insufficiency in IUGR pregnancies.
The use of PHT cells contributes to the relevance of our studies to human physiology and the demonstration of
decreased protein expression of mitochondrial ETC complexes in human IUGR placentas highlights the potential
clinical impact of our findings. Although mTOR is known as the master regulator of protein translation, our data
show that mTOR has a profound influence on trophoblast mitochondrial ETC gene expression, with mTORC1 and
mTORC2 showing differential regulation. Importantly, mTORC1, but not mTORC2, constitutes a positive regulator of
trophoblast mitochondrial respiration mediated by changes in the expression of genes representing all five complexes
of the electron transport chain. By controlling trophoblast production of ATP, which is critical for active transport and
protein synthesis, and regulating plasma membrane trafficking of amino acid transporters25, mTORC1 links nutrient
and oxygen availability and growth factor signaling to placental function. Our findings are consistent with the possibility that reduced placental mTOR activity in IUGR18–20 may impair mitochondrial respiration and contribute to
placental insufficiency in this pregnancy complication. However, the available literature assessing mitochondrial DNA
and expression of ETC complexes in the human IUGR placenta is not entirely consistent. For example, whereas some
investigators have reported that IUGR is associated with decreased placental mitochondrial DNA content49,50, others
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Figure 5. Regulation of PHT cell ATP levels, mitochondrial DNA (mtDNA) copy number, and citrate
synthase activity by mTOR signaling. (a–c) ATP levels were normalized to total protein level of cell lysates.
(d–f) Mitochondrial numbers assessed by mtDNA copy number. mtDNA copy number was normalized to
nuclear DNA (nDNA) (β2-microglobulin) for each sample. (g–i) Mitochondrial numbers estimated by citrate
synthase activity. Data are presented as mean + S.E.M. *P < 0.05 vs scramble siRNA cells, n = 6 independent
experiments. The number of experiments (n) represents the number of placentas studied.

found higher mitochondrial DNA content in the human IUGR placenta51–53. Furthermore, Mando52 and coworkers
reported that mtDNA content and expression of genes encoding for ETC proteins were decreased whereas ETC protein
expression was unaltered and ETC activity was increased in cultured trophoblast cells isolated from IUGR placentas52.
The reasons for the divergent findings in the different studies remains to be established.
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Figure 6. Visualization of mitochondria in PHT cells using immunofluorescence. Trophoblast cells were
transfected at 18 h in culture with scramble (a) or raptor (b) siRNA. At 90 h in culture, cells were incubated with
mitochondrial dye and fixed and mitochondria (green) were visualized using immunofluorescence. The data are
from a representative experiment, and similar results were obtained from three other experiments. Nuclei were
counterstained using DAPI (4′,6-diamidino-2-phenylindole) (blue); scale bar 50 µm. (c) Histogram summarizes
the syncytiotrophoblast mitochondrial staining intensity in PHT cells transfected with either scramble or raptor
siRNA. In each section, at least five randomly selected microscopic fields were used to calculate staining density
per mm2 using Image J and data were averaged to represent a single placenta. Values are given as mean + SEM;
*P < 0.05 vs scramble siRNA; unpaired Student’s t-test; n = 4 placenta/each group.
Inhibition of mTORC1 resulted in a highly coordinated transcriptional response of genes related to oxidative
phosphorylation, which is consistent with the finding that mitochondrial function was the top-ranked pathway
affected by raptor silencing. Specifically, genes in all mitochondrial complexes were down-regulated in PHT cells
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Figure 7. Correlation between placental mTORC1 functional readouts and protein expression of
mitochondrial ETC complex I. (a) Protein expression of mitochondrial electron transport chain complexes
in placental homogenates of control and IUGR group. Representative Full length Western blot is shown. (b)
Relative expression of mitochondrial electron transport chain complex I expression in placental homogenates
of control and IUGR. After normalization to β-actin, the mean density of C samples was assigned an arbitrary
value of 1. Subsequently, individual IUGR density values were expressed relative to this mean. (c–e) Correlation
between placental mTORC1 functional readouts S6KT-389 (c), 4E-BP1 T-37/46 (d) 4E-BP1 (e) and mitochondrial
ETC complex I expression. r = Pearson correlation coefficient, n = Control, 19; IUGR, 25. Values are given as
means ± S.E.M.; *P < 0.05 vs. control; unpaired Student’s t test.
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Figure 8. A proposed model linking mTORC1 inhibition, mitochondrial respiration and fetal growth
restriction. Placental mTORC1 signaling is inhibited in fetal growth restriction, we speculate that decreased
trophoblast mitochondrial respiration and ATP production may link placental mTORC1 inhibition in placental
insufficiency to restricted fetal growth. Abbreviation: MVM: Microvillus plasma membrane; BM: Basal plasma
membrane; mt: Mitochondria.

following mTORC1 inhibition. This effect is likely to be mediated, at least in part, by mTORC1 inhibition of mitochondrial biogenesis, as evidenced by decreased cellular ATP levels, citrate synthase activity and mitochondrial
copy number in raptor silenced cells.
Previous studies show that muscle-specific knockout of raptor in mice results in down-regulation of mitochondrial gene expression and decreased oxidative capacity29. Furthermore, rapamycin treatment or knockdown
of mTOR or raptor in muscle cells or in MCF7 cells decreases mitochondrial gene expression and oxygen consumption27,45,46. Tuberous sclerosis complex (TSC) 1 and 2 form a heterodimeric complex and inactivate Ras
homolog enriched in brain, resulting in inhibition of mTORC1. TSC2−/− knock out in MEFs exhibited hyperactivation of mTORC1 signaling54 and an increased expression of mitochondrial genes that were downregulated by
rapamycin27. Loss of TSC2 in MEF’s increased mitochondrial respiration and mitochondrial DNA content and
ATP levels46. Furthermore, in the absence of DEPTOR, mTORC1 remains active, which promotes liver mitochondrial oxidative metabolism. Consistent with previous findings27,46, in the present study, we found that mTOR
activation by silencing DEPTOR in PHT cells increased the mitochondrial oxidative phosphorylation and ATP
synthesis. These results further support the finding that mTORC1 signaling positively controls mitochondrial
gene expression and oxygen consumption in an mTORC2 independent manner. Taken together, our data in primary human trophoblast cells and previous studies in other cell systems demonstrate that mTORC1 controls
mitochondrial respiration, thereby linking increased nutrient availability and activation of growth factor signaling to increased capacity for cellular energy production in an integrated response to promote cellular growth.
Mitochondrial biogenesis also involves an increase of mitochondrial import55. In differentiating C2C12 cells
overexpression of Tom20 increases and the inhibition of Tom20 decreases the mitochondrial import, demonstrating the critical importance of Tom20 in determining the mitochondrial capacity to important cytosolic proteins56.
Furthermore, the use of anti-Tom20 antibodies reduces the import of several mitochondrial proteins57. In our
study, the mitochondrial Tom20 protein level was reduced by mTORC1 inhibition, which may be secondary to
the decreased mitochondrial number and/or as a result of mTORC1 directly regulating Tom20 expression.
To our knowledge, this is the first study showing mTORC1 regulation of mitochondrial function in trophoblast cells. However, the molecular mechanisms linking mTORC1 inhibition to decreased mitochondrial biogenesis in PHT cells remain to be established. Long-term inhibition of mTORC1 with rapamycin was found to
decrease PGC-1α (Peroxisome-proliferator-activated receptor coactivator-1α) mediated gene transcription in
muscle cells in vitro, possibly mediated by the yin-yang 1 (YY1) transcription factor27. As a result, mitochondrial
DNA content and oxygen consumption were lowered27. Reduction in energetic capacity renders cells more susceptible to stressors58.
Placental mitochondrial dysfunction has been proposed to represent one mechanism underlying fetal programming in cases of placental insufficiency5. In mouse embryos, altered mitochondrial function affects fetal
and placental growth59, and conversely, restricted fetal growth induced by maternal under-nutrition in rats is
associated with impaired placental mitochondrial function6. A multitude of nutrient transporters, including
amino acid, vitamin and calcium transporters, mediate active transport across the placental barrier and therefore
requires a continuous supply of ATP. Although a significant portion of trophoblast ATP is produced by the glycolytic pathway, the majority is likely to be derived from mitochondrial respiration. Thus, impaired mitochondrial
function and decreased placental ATP production3, may link placental mTORC1 inhibition in placental insufficiency18,22 to restricted fetal growth.
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We demonstrated that protein expression of mitochondrial ETC complexes were decreased in human IUGR
placentas. In addition, placental mTORC1 signaling functional readouts were positively correlated with the protein expression of placental mitochondrial ETC complexes. These findings suggest that our study has relevance to
clinically important pregnancy complications. In addition, given that trophoblast mitochondrial respiration can
be directly modulated by mTOR signaling, we speculate that activation of placental mTOR signaling to promote
energy production may be a target of interest in future development of novel intervention strategies in IUGR.
In conclusion, mTORC1, but not mTORC2, is a positive regulator of the trophoblast expression of genes
encoding ETC proteins and mitochondrial respiratory function, likely mediated by effects on mitochondrial biogenesis. By controlling trophoblast production of ATP, which is critical for active transport and protein synthesis,
and regulating plasma membrane trafficking of amino acid transporters25, mTOR functions as a placental nutrient
sensor linking nutrient and oxygen availability and growth factor signaling to placental function and fetal growth.
Because placental mTORC1 signaling is inhibited in fetal growth restriction, we speculate that decreased mitochondrial respiration induced by inhibition of mTORC1 signaling directly contributes to placental insufficiency
in this pregnancy complication (Fig. 8).
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